PHGDH, the first rate-limiting enzyme in the SSP, is high-expressed in various metabolic disorders, including cancer and glucose metabolism [24,25,26], to produce serine supplying one-carbon unit for the synthesis of nucleotide to meet the need of tumor cell growth. Here, PHGDH is linked to neoplasm.